Mark Sullivan - General Counsel & Secretary at Carisma Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel & Secretary
Stock Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Sullivan since 12/22/2023

Holdings reported by Mark Sullivan for Carisma Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 379K $222K $0.59 Mar 2, 2023 Direct

Transactions reported by Mark Sullivan for Carisma Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.